Results for post marketing adr translation from English to Maltese

post-marketing
wara t-tqegħid fis-suq

post-marketing:
91 wara l- bejgħ:

post – marketing data
dejta ta’ wara t-tqegħid fis-suq

post marketing experience
esperjenza ta’ wara t-tqegħid fis-suq.

post-marketing surveillance
sorveljanza ta’ wara t-tqegħid fis-suq

# adrs identified from post-marketing surveillance
# adrs identifikati minn dejta ta’ sorveljanza ta’ wara l-introduzzjoni tal-prodott fis-suq

2 adrs derived only during post-marketing
2 adrs derivati biss wara t-tqegħid fis-suq

the following adrs have been reported in the post-marketing experience:
dawn l-adrs li ġejjin ġew irrapportati fl-esperjenza ta’ wara t-tqegħid fis-suq:

for spontaneous post-marketing adrs, the reporting frequency is categorized as unknown.
għal adrs spontanji wara t-tqegħid fis-suq, il-frekwenza ta’ rappurtar hija kkategorizzata bħala mhux magħrufa.

table 4: adrs reported in post-marketing use in patients treated with lenalidomide
tabella 4: adrs irrappurtati fl-użu ta’ wara t-tqegħid fis-suq f’pazjenti kkurati b’lenalidomide

there have been cumulatively 2179 adverse drug reactions (adr) reports from post-marketing sources.
minn sorsi wara li l-prodott tqiegħed fis-suq, b’mod kumulattiv kien hemm 2179 rapport ta’ reazzjonijiet avversi għall-mediċina (adr- adverse drug reactions).

the most reported post-marketing adrs received since the product was authorised for both concentrations were chest pain, flushing, blood pressure increased and decreased, malaise, dyspnoea, nausea, vomiting pyrexia, back pain, headache and chills.
l-iktar adrs li ġew irrappurtati wara t-tqegħid fis-suq li ġew riċevuti minn meta l-prodott ġie awtorizzat għaż-żewġ konċentrazzjonijiet kienu wġigħ fis-sider, fwawar, żieda u tnaqqis fil-pressjoni tad-demm, telqa, qtugħ ta’ nifs, dardir, rimettar, deni, uġigħ fid-dahar, uġigħ ta’ ras u tertir.